Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia - Hanny Al-Samkari; Josefien Hessels; Antoni Riera-Mestre; Sophie Dupuis-Girod; Thibaut Van Zele; Vicente Gómez del Olmo; Pamela G. Hodges; Raquel Torres-Iglesias; Roberto Bertè; Pierre Saint-Mezard; Hedvika Lazar; Nicholas Benedict; et al. (New England Journal of Medicine, 2025)